The complex interplay between the human brain and behavior has long fascinated scientists and laypeople alike, particularly when it comes to understanding the roots of violence. A recent study showcases the hypothalamus, a small but crucial brain region, revealing its significant role in aggression and violent behavior. Highlights: Hypothalamic Volume Reductions Linked to Violence: Studies …
In the intricate world of mental health, the rhythms of our body’s natural processes play a pivotal role, particularly the circadian rhythm of melatonin, a hormone primarily produced by the pineal gland. Recent research suggests that variations in melatonin’s circadian rhythm might not only distinguish between depression and bipolar disorder but also correlate with the …
In the intricate puzzle of autism spectrum disorders (ASD), emerging research highlights a fascinating piece: the role of adiponectin, an anti-inflammatory adipokine, in the development and severity of ASD in children. With the backdrop of increasing ASD prevalence and the quest for biomarkers for early identification, the exploration of adiponectin offers a promising avenue for …
Recent research has analyzed the relationship between the use of Anabolic Androgenic Steroids (AAS), sleep quality, and psychological distress. A new study specifically evaluated the effects of anabolic steroids on sleep patterns during both active use and withdrawal phases, among male weightlifters in Norway. Highlights: A large proportion of men using AAS report experiencing sleep …
In the quest to understand the alarming rise in obesity rates worldwide, recent research has pointed towards a surprising culprit: endocrine-disrupting chemicals (EDCs), such as bisphenol A (BPA) and phthalates. These chemicals, ubiquitous in our environment, have been linked to significant disturbances in the hormonal regulation of body mass and adipose tissue function. Highlights: Endocrine …
Geodon (Ziprasidone) is an atypical antipsychotic that was approved by the FDA in 2001 for the treatment of schizophrenia. It has since been approved to manage both manic and mixed states of bipolar disorder. In some cases, the drug is used as an antidepressant augmentation strategy for the treatment of refractory depression, as well as …
Zyprexa (Olanzapine) is an atypical antipsychotic medication that is approved by the FDA for the treatment of schizophrenia and bipolar disorder. In relatively rare cases, it is used as an augmentation strategy for the treatment of depression. The drug is manufactured by the company Eli Lilly, and has generated billions of dollars in revenue. Despite …